Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 31, 2005

View Archived Issues

Peregrine signs licensing agreement with Medarex for vascular targeting agents

New preclinical data support use of OXI-4503 in cancer

Inyx to acquire Celltech Manufacturing Services from UCB

EncorePharma receives phase I SBIR grant for Huntington's disease research

Acambis on track to begin phase III trials of ChimeriVax-JE by year-end

AL-208 enters phase I trials for MCI associated with CABG

Sunesis selects Aurora kinase candidate for preclinical development

New study evaluates Cotara for glioblastoma multiforme

Advaxis completes preclinical toxicology studies for Lovaxin C

SCOLR Pharma completes pilot bioavailability testing of CDT-raloxifene

Enrollment completed in phase II study of ozarelix for prostate cancer

Discovery receives FDA notification regarding Surfaxin response letter

Positive findings in open-label study of Prestara

Preclinical profile of AMG-8163 for the treatment of pain

Preclinical summary on ONO-2921, a Cav2.2 blocker for pain

Actoplus Met approved for type 2 diabetes

sBLA filed for Erbitux for head and neck cancer

New data on Remune presented

CHIR-258 active against acute myelogenous leukemia cells in vitro and in vivo

Novel BK-1 antagonist with high selectivity and good PK profile

TAK-242 subject of presentation at ACS meeting

Maraviroc reported safe and effective in HIV infection

EGIS-11229: A novel noncompetitive AMPA receptor antagonist

Case report: Reboxetine induces weight loss

Recent patents describe novel antiinfective agents

New potential treatments for obesity emerge from pharmaceutical R&D

Novel agents for thrombotic disorders imparted by AstraZeneca

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 26, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...